In clinic, immunosuppressive phenotypes, such as upregulated G-CSF, tumor-related leukocytosis, and neutrophil-to-lymphocyte (NLR), are associated with poor outcome of non-small cell lung cancer (NSCLC) patients [11]. Here, CSF3 is linked to non-small cell lung carcinoma.